The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Expert Panel opinion «Possibilities of Cytoflavin in Patients with Diabetic Polyneuropathy» based on the results of the study «Efficacy and safety of combined metabolic medication containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multiple-center randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER)»
Journal: Russian Journal of Pain. 2023;21(3): 59‑65
Views: 4133
Downloaded: 118
To cite this article:
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.